Akshaya Srinivasan

Akshaya Srinivasan

Auto-generated profile, based on publicly available information

Akshaya Srinivasan

Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2019 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
ASAkshaya Srinivasan
Akshaya Srinivasan
YTYi-Chin Toh
Yi-Chin Toh
Neural crest cells (NCCs) are a multipotent and migratory cell population in the developing embryo that contribute to the formation of a wide range of tissues. Defects in the development, differentiation and migration of NCCs give rise to a class of syndromes and diseases that are known as neurocristopathies. NCC development has historically been studied in a variety of animal models, including xenopus, chick and mouse. In the recent years, there have been efforts to study NCC development and disease in human specific models, with protocols being established to derive NCCs from human pluripotent stem cells (hPSCs), and to further differentiate these NCCs to neural, mesenchymal and other lineages. These in vitro differentiation platforms are a valuable tool to gain a better understanding of the molecular mechanisms involved in human neural crest development. The use of induced pluripotent stem cells (iPSCs) derived from patients afflicted with neurocristopathies has also enabled the study of defective human NCC development using these in vitro platforms. Here, we review the various in vitro strategies that have been used to derive NCCs from hPSCs and to specify NCCs into cranial, trunk, and vagal subpopulations and their derivatives. We will also discuss the potential applications of these human specific NCC platforms, including the use of iPSCs for disease modeling and the potential of NCCs for future regenerative applications.

25 February 2022 in Cytotherapy
Verified
Journal Article
Closed access
ASAkshaya Srinivasan
Akshaya Srinivasan
PSPadmapriya Sathiyanathan
Padmapriya Sathiyanathan
LYLu Yin
Lu Yin
TLTong Ming Liu
Tong Ming Liu
ALAlan Lam
Alan Lam
SCSimon M. Cool
Simon M. Cool

21 July 2020 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
SASeep Arora
Seep Arora
ASAkshaya Srinivasan
Akshaya Srinivasan
CLChak Ming Leung
Chak Ming Leung
YTYi-Chin Toh
Yi-Chin Toh
Mesenchymal stem cells (MSCs) are multipotent stromal cells, with the ability to differentiate into mesodermal (e.g., adipocyte, chondrocyte, hematopoietic, myocyte, osteoblast), ectodermal (e.g., epithelial, neural) and endodermal (e.g., hepatocyte, islet cell) lineages based on the type of induction cues provided. As compared to embryonic stem cells, MSCs hold a multitude of advantages from a clinical translation perspective, including ease of isolation, low immunogenicity and limited ethical concerns. Therefore, MSCs are a promising stem cell source for different regenerative medicine applications. The in vitro differentiation of MSCs into different lineages relies on effective mimicking of the in vivo milieu, including both biochemical and mechanical stimuli. As compared to other biophysical cues, such as substrate stiffness and topography, the role of fluid shear stress (SS) in regulating MSC differentiation has been investigated to a lesser extent although the role of interstitial fluid and vascular flow in regulating the normal physiology of bone, muscle and cardiovascular tissues is well-known. This review aims to summarise the current state-of-the-art regarding the role of SS in the differentiation of MSCs into osteogenic, cardiovascular, chondrogenic, adipogenic and neurogenic lineages. We will also highlight and discuss the potential of employing SS to augment the differentiation of MSCs to other lineages, where SS is known to play a role physiologically but has not yet been successfully harnessed for in vitro differentiation, including liver, kidney and corneal tissue lineage cells. The incorporation of SS, in combination with biochemical and biophysical cues during MSC differentiation, may provide a promising avenue to improve the functionality of the differentiated cells by more closely mimicking the in vivo milieu.

1 June 2018 in Biomaterials
Verified
Journal Article
Closed access
ASAkshaya Srinivasan
Akshaya Srinivasan
SCShu-Yung Chang
Shu-Yung Chang
SZShipin Zhang
Shipin Zhang
WTWei Seong Toh
Wei Seong Toh
YTYi-Chin Toh
Yi-Chin Toh

22 November 2013 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CFChui‐Yee Fong
Chui‐Yee Fong
ABArijit Biswas
Arijit Biswas
ASArjunan Subramanian
Arjunan Subramanian
ASAkshaya Srinivasan
Akshaya Srinivasan
MCMahesh Choolani
Mahesh Choolani
ABAriff Bongso
Ariff Bongso

30 November 2016
Verified
Book Chapter
Closed access
PDF file
ASAkshaya Srinivasan
Akshaya Srinivasan
YTYi-Chin Toh
Yi-Chin Toh
Xian Jun LohXian Jun Loh
Xian Jun Loh
WTWei Seong Toh
Wei Seong Toh